吉(ji)林敖(ao)(ao)東(dong)藥(yao)(yao)業(ye)(ye)(ye)(ye)集(ji)(ji)團(tuan)(tuan)股(gu)份(fen)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)的(de)前身(shen)是1957年成(cheng)立的(de)國營延邊敦化(hua)鹿(lu)場(chang)，于1981年建立敖(ao)(ao)東(dong)制藥(yao)(yao)廠，1993年3月經省體改(gai)委批準改(gai)制為吉(ji)林敖(ao)(ao)東(dong)藥(yao)(yao)業(ye)(ye)(ye)(ye)集(ji)(ji)團(tuan)(tuan)股(gu)份(fen)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)，1996年10月28日在深交所掛(gua)牌上市(shi)。公(gong)(gong)(gong)(gong)(gong)司(si)(si)現(xian)共控股(gu)5家(jia)從事現(xian)代(dai)(dai)中藥(yao)(yao)、生物化(hua)學藥(yao)(yao)和植物化(hua)學藥(yao)(yao)的(de)專業(ye)(ye)(ye)(ye)制藥(yao)(yao)子公(gong)(gong)(gong)(gong)(gong)司(si)(si)，9家(jia)醫(yi)藥(yao)(yao)銷售子公(gong)(gong)(gong)(gong)(gong)司(si)(si)，8家(jia)醫(yi)藥(yao)(yao)配套子公(gong)(gong)(gong)(gong)(gong)司(si)(si)，2家(jia)高端保(bao)健品公(gong)(gong)(gong)(gong)(gong)司(si)(si)，1家(jia)公(gong)(gong)(gong)(gong)(gong)路建設收費(fei)公(gong)(gong)(gong)(gong)(gong)司(si)(si)，1家(jia)敖(ao)(ao)東(dong)國際(ji)（香港）實(shi)業(ye)(ye)(ye)(ye)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)，擁有種植、養殖基(ji)(ji)地，建立了(le)“公(gong)(gong)(gong)(gong)(gong)司(si)(si)+標(biao)準化(hua)基(ji)(ji)地+特(te)許農(nong)戶”的(de)產業(ye)(ye)(ye)(ye)鏈經營模式，逐(zhu)步發展成(cheng)為以醫(yi)藥(yao)(yao)產業(ye)(ye)(ye)(ye)為基(ji)(ji)礎(chu)，以“產業(ye)(ye)(ye)(ye)＋金融”雙(shuang)輪驅動模式迅速發展的(de)控股(gu)型集(ji)(ji)團(tuan)(tuan)上市(shi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)。目前公(gong)(gong)(gong)(gong)(gong)司(si)(si)是廣發證(zheng)(zheng)(zheng)券(quan)(quan)股(gu)份(fen)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡稱(cheng)：廣發證(zheng)(zheng)(zheng)券(quan)(quan)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼(ma)：000776.SZ，1776.HK）的(de)大(da)股(gu)東(dong)，同時投資遼寧(ning)成(cheng)大(da)股(gu)份(fen)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡稱(cheng)：遼寧(ning)成(cheng)大(da)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼(ma)：600739）、上海第一醫(yi)藥(yao)(yao)股(gu)份(fen)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡稱(cheng)：第一醫(yi)藥(yao)(yao)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼(ma)：600833.SH）、吉(ji)林亞泰(集(ji)(ji)團(tuan)(tuan))股(gu)份(fen)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡稱(cheng)：亞泰集(ji)(ji)團(tuan)(tuan)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼(ma)：600881.SH）、南京醫(yi)藥(yao)(yao)股(gu)份(fen)有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡稱(cheng)：南京醫(yi)藥(yao)(yao)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼(ma)：600713.SH）、吉(ji)林博雅特(te)醫(yi)營養科技有限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)等。

公司產(chan)品“安神(shen)補腦(nao)液(ye)(ye)(ye)(ye)”、“注射用核(he)糖核(he)酸II”、“小牛(niu)脾提取物注射液(ye)(ye)(ye)(ye)”、“血府逐(zhu)瘀口服(fu)液(ye)(ye)(ye)(ye)”、“腦(nao)心(xin)舒口服(fu)液(ye)(ye)(ye)(ye)”、“小兒柴桂退熱口服(fu)液(ye)(ye)(ye)(ye)”、“養血飲口服(fu)液(ye)(ye)(ye)(ye)”、“心(xin)腦(nao)舒通膠(jiao)(jiao)囊”、“羚貝止咳(ke)糖漿(jiang)”、“利腦(nao)心(xin)膠(jiao)(jiao)囊”、“少(shao)腹逐(zhu)瘀顆(ke)粒”、“腎復(fu)康(kang)片”、“賴(lai)氨匹林”、“復(fu)方二(er)氯醋酸二(er)異丙(bing)胺注射液(ye)(ye)(ye)(ye)”、“孕康(kang)顆(ke)粒”、“根(gen)痛(tong)平(ping)丸(wan)”、“伸(shen)筋(jin)片”、“澳泰樂膠(jiao)(jiao)囊”、“鹿胎顆(ke)粒”、“注射用單(dan)磷(lin)酸阿糖腺苷”、“小兒氨酚黃那敏顆(ke)粒”、“中(zhong)風再造丸(wan)”等以質量穩定、療效明顯受到市場(chang)一致好評，促(cu)進了公司醫藥主業不斷發展(zhan)壯(zhuang)大。

公司秉持(chi)(chi)“專(zhuan)注于(yu)人，專(zhuan)精于(yu)藥(yao)(yao)”的(de)核心價值觀，堅持(chi)(chi)“大(da)品種(zhong)群、多品種(zhong)群”齊頭(tou)并(bing)進的(de)醫(yi)藥(yao)(yao)產業發(fa)展(zhan)(zhan)戰(zhan)略，堅持(chi)(chi)走“產業+金融(rong)”雙輪驅動的(de)發(fa)展(zhan)(zhan)道路，順應醫(yi)藥(yao)(yao)行業發(fa)展(zhan)(zhan)趨(qu)勢，積極發(fa)揮自身(shen)優勢，夯實(shi)穩健發(fa)展(zhan)(zhan)的(de)局面，努力實(shi)現“為社會提供(gong)安全、可信、放心藥(yao)(yao)”的(de)企業使命(ming)。